Bringing New Horizons to Therapy
A recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally-invasive medical devices for urology based upon proprietary ultrasound technology.
With its complete range of robotic High Intensity Focused Ultrasound (HIFU) devices, EDAP TMS is a globally recognized innovator in non-invasive ablation for prostate tissue. By combining the latest technologies in imaging and treatment modalities, EDAP TMS introduced the Focal One® (currently pending FDA clearance) in 2013 as the answer to all requirements for ideal focal prostate tissue ablation as a complement to the existing Ablatherm® Robotic HIFU and Ablatherm® Fusion (both FDA cleared). EDAP Technomed Inc. is the company’s wholly owned subsidiary responsible for operations in the United States.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS introduced the first modular lithotripter. The latest generation of shock wave source is utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).
Brands: Ablatherm Fusion